# Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair

> **NCT02168439** · PHASE4 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 40 (actual)

## Conditions studied

- Laceration
- Anxiety

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT02168439
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-04
- **Final completion:** 2016-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-11-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168439, "Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT02168439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*